SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-005388
Filing Date
2017-09-05
Accepted
2017-09-05 16:16:10
Documents
2
Period of Report
2017-09-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_090517.htm 8-K 12891
2 EXHIBIT 99.1 exh_991.htm EX-99.1 8333
  Complete submission text file 0001171843-17-005388.txt   22333
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37539 | Film No.: 171068924
SIC: 2834 Pharmaceutical Preparations